Nidan Laboratories and Healthcare Limited is an India-based company. The Company is engaged in providing diagnostic services including pathology, radiology, cardiology, and neurology. Its laboratory tests offer a range of over 6000 clinical laboratory tests and profiles, which are used to provide diagnostic services for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease using technological advanced machines, prenatal screening, to screening for hormonal imbalance, nutritional deficiencies, and tracking lifestyle disorders. Its services include computed tomography (CT) scans, X-radiation (X-ray), pathology, cardio, magnetic resonance imaging (MRI), sonography, outpatient department (OPD) and others. Its lab tests include CT Lower Limb Arteriography And Venography, CT Whole Spine, CT Abdomen Angiography, CT Lumber Spine, CT Calcium Scoring, Dry Film D12, CT Extra Report and others.As of 26 May 2026, NIDAN LABS AND HEALTH LTD share price is ₹14.95. The stock opened at ₹14.55, compared to its previous close of ₹14.35. During today's trading session, NIDAN LABS AND HEALTH LTD share price moved in the range of ₹14.10 to ₹15.00, with an average price of ₹14.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹14.10 and a high of ₹15.00. On the performance front, NIDAN LABS AND HEALTH LTD share price has declined by 18.31% over the last six months and is down 23.33% on a year-on-year basis.
The market capitalization of NIDAN LABS AND HEALTH LTD is ₹20 Crs, with a P/E ratio of 11.7 and a dividend yield of 0.00%.